Home Study Activities

340B Drug Pricing - Update on Legislative, Regulatory and Political Landscape

This activity will discuss the 340B legal and regulatory landscape including manufacturer actions regarding contract pharmacies and other regulatory and agency developments.

Learn More ►

A Call to Action: Dedicated Medication Safety Transformation in the Perioperative Setting

This activity will focus on the daily challenges of ensuring medication safety in the high-risk perioperative or procedural setting, highlighting the national aggregate findings and practice gaps identified using ISMP's Medication Safety Self Assessment for Perioperative Settings.

Learn More ►

A Deep Dive into the Role of PARP Inhibitors: Equipping Healthcare Professionals with the Necessary Tools for Improving Care in Ovarian Cancer

This activity will improve the knowledge and competency of pharmacists, nurses, and other healthcare professionals about the role of PARP inhibitors in ovarian cancer and the management of adverse events associated with PARP inhibitors.

Learn More ►

A Review in the Treatment Options for Renal Cell Cancer

This activity will review the treatment options for patients with metastatic RCC. The pharmacological treatments available, appropriate use, adverse events, monitoring of agents, and management of adverse events will also be discussed. Future therapies and emerging agents will also be explored.

Learn More ►

A Specialty Pharmacy Pipeline Product Update

An update on what is in the pipeline is the focus of this presentation. The most recent approvals and near-term products will be covered.

Learn More ►

Adherence Concepts for the Cancer Patient

This educational activity will address the issue of adherence in the oncology patient. Topics to be addressed include the incidence of non-adherence, reasons for non-adherence, and consequences of non-adherence. Strategies to remove barriers to non-adherence and improve the adherence rate will be discussed.

Learn More ►

An Introduction to Gene and Disease-modifying Therapies in Specialty Pharmacy

This activity will briefly review key background information and definitions and then discuss gene therapy, disease-modifying treatments and patient considerations following therapy.

Learn More ►

Antibiotic De-escalation: Preventing Resistance or Futile Existence?

Expert faculty will debate the pros and cons of Antibiotic De-escalation. Primary literature and guidelines recommendations regarding de-escalation and antibiotic resistance will frame the basis for this discussion as best practices are identified.

Learn More ►

Arming Specialty Pharmacies with Standards-Based Technologies to Engage Patients and Prescribers

This panel discussion will examine how standards-based technology solutions are aiding specialty pharmacies. Topics will include a review of the landscape of specialty pharmacy and standards, specialty pharmacist-related opioid issues and improving patient onboarding to specialty medications.

Learn More ►

Atopic Dermatitis

At the end of this presentation learners should understand the clinical presentation, risk factors and treatment options of Atopic Dermatitis.

Learn More ►

Awareness or Distraction: Has COVID-19 Shown Us a Path Forward for Combatting Drug Resistant Infections?

Join CIDRAP-ASP for a webinar reviewing how infection prevention practices utilize diagnostics, and how improved utilization can decrease the burden of drug resistant infections.

Learn More ►

Best Practices for the Safe and Cost-Effective Management of Controlled Substances

This session will provide guidance to assess an organization’s medication-use processesfor vulnerabilities and identify strategies that may improve the capacity to preventor detect diversion.

Learn More ►

Billing & Financial Assistance in Specialty Pharmacy

This activity will address pharmacy billing in a specialty setting. Benefit types, basic billing, details pertaining to Medicare Part B billing and common rejection codes will be discussed.

Learn More ►

Biosimilar Action Plan

This activity will review FDA Biosimilar Action Plan & Ancillary Policies. Faculty will discuss plans to increase biosimilar access and key actions the FDA is taking.

Learn More ►

Blood Boiling Debate: Can I Really Use Ceftriaxone for MSSA Bacteremia?

This blood boiling debate will try to convince participants of the utility or fatality of trusting ceftriaxone to treat MSSA bacteremia by reviewing both in vitro and in vivo literature.

Learn More ►

Breast Cancer: An Overview and Current Treatment Strategies

This activity will provide an overview of the epidemiology, risk factors, pathology, and staging of breast cancer. Standard treatment regimens for non-metastatic and metastatic disease will be reviewed with a focus on oral chemotherapy and targeted therapies.

Learn More ►

Building Partnerships with Drug Manufacturers & Payors: How Health System Specialty Pharmacies Can Use Data to Enhance Care & Create Synergies with Stakeholders

This panel discussion will review key data points and patient-reported outcomes measures. Ways to measure disease-specific outcomes will also be examined.

Learn More ►

Call to Action: Experience in Adopting the ENFit System to Guard Against Accidental Tubing Misconnections

Join ISMP faculty as they review the many challenges associated with wrong route errors, discuss the product design concerns that led to the re-engineering of the new ISO standard and the low-dose tip syringe. Most importantly, we will highlight the patient safety benefits to an ENFit transition.

Learn More ►

Certification in Specialty Pharmacy Exam - Preparation Course

The CSP Exam Preparatory Course will cover aspects of Clinical, Fulfillment, Intake and Outcomes that might be expected on the exam. Join expert faculty as key aspects of specialty pharmacy and the specialty pharmacist’s role are discussed.

Learn More ►

Chronic Inflammatory Disease: An Introduction

This activity will review the pathophysiology and etiology of the inflammatory process along with identifying some of the pharmacological approaches to treating chronic inflammatory disease.

Learn More ►

Clinical Updates on Inflammatory Bowel Disease: Need to Know Information for Managed Care Professionals

As medication therapy experts, pharmacists can aid in both the clinical and financial management of IBD. The goal of this activity is to improve the knowledge and competence of pharmacists about evidence-based recommendations for the treatment of moderate to severe UC and CD, therapeutic drug monitoring for biologic therapy, clinical data on emerging therapies, and strategies for pharmacists to optimize patient care.

Learn More ►

Colorectal Cancer

This educational activity will provide an overview of the epidemiology, risk factors, pathology, and staging of CRC. Common treatments used for CRC will be reviewed along with a discussion of adverse effects and recommended monitoring. Strategies to improve the compliance and adherence in CRC patients will also be discussed.

Learn More ►

Copay Accumulators, Maximizers, and the Impact for Specialty

This activity will discuss copay accumulators and maximizers, patient out of pocket expense and operational challenges. Case study scenarios will be used to examine patient challenges.

Learn More ►

COVID-19 Monoclonal Antibody Toolkit

This activity is intended to educate pharmacists on available mAb therapeutics, highlight their role in treatment and PEP of COVID-19, and provide resources for infusion sites offering mAb to patients. The latest toolkit is available at www.SIDP.org.

Learn More ►

Critical Updates in the Treatment of HIV and STIs

This activity will discuss updates in HIV therapy, particularly two-drug regimens. The faculty will also review STI treatment guideline updates.

Learn More ►

Cystic Fibrosis Module #1: Cystic Fibrosis: An Overview

Module 1 will provide an overview of CF disease. The metabolism differences to consider in CF patients will also be addressed.

Learn More ►

Cystic Fibrosis Module #2: Chronic Medications: Changing the Course of Cystic Fibrosis

Module 2 reviews the chronic medications used in CF patients. It will also discuss some of the future directions being explored with medications for CF.

Learn More ►

Cystic Fibrosis Module #3: Management of Acute Pulmonary Exacerbations: Pseudomonas and Beyond

Module 3 addresses the management of infections in CF patients and the use of antibiotics in CF patients. It will review the pharmacokinetic and pharmacodynamic considerations to in these patients.

Learn More ►

Cystic Fibrosis Module #4: Adherence, Access, Education: Current Challenges and Overcoming Barriers in CF Medications

Module 4 discusses the importance of adherence in CF patients and will address the role of education to improve the treatment of CF patients.

Learn More ►

Desensitization to Antibiotic Allergies

This activity will use five clinical scenarios to explore treatment options for patients with antibiotic allergies.

Learn More ►

Dismantling Structural Racism in Pharmacy: Why it Matters to Our Underrepresented Minority Community

This activity will provide key definitions as a basis for discussion of systemic and structural racism in communities and the pharmacy profession. A case study will be used to highlight aspects of this topic and focus on ways to improve the health of the community through diversity, equity and inclusion.

Learn More ►

Documentation and Communication Etiquette

This activity is designed to strengthen skills to support the need for equal understanding from all perspectives, encourage respectful and tactful communication, and promote satisfactory etiquette. This module will allow the reader to be able to distinguish between correct and incorrect communication and etiquette for the professional specialty pharmacy environment.

Learn More ►

Early Antifungals in the ICU: Untangling the Unnecessarily Complex

This activity will focus on antifungals and discuss evidence regarding their use on invasive candidiasis in critically ill patients. Non-culture diagnostic techniques will also be evaluated.

Learn More ►

Emerging Insights on the Role of Monoclonal Antibodies in Patients with COVID-19

This activity will improve the knowledge and competency of pharmacists and nurses about the stages of COVID-19 and the role disease progression plays in therapeutic options, the safety and efficacy data for monoclonal antibodies for use in COVID-19, and best practices for the use of monoclonal antibodies in patients with COVID-19.

Learn More ►

Enzyme Replacement Therapies

Three LSDs will be discussed including Gaucher disease, Anderson-Fabry disease and Pompe disease. For each disease, biomarkers, symptoms, complications, and other therapeutic options besides ERTs will be addressed. Pharmacists may benefit from learning drug therapies for these rare diseases.

Learn More ►

Expanding the Impact of Antimicrobial Stewardship (Act Local)

Join CIDRAP-ASP for a webinar reviewing the importance of data generated by diagnostic laboratories, and how these data can be efficiently connected with clinical outcomes and used in infection prevention strategies to prevent or disrupt outbreaks.

Learn More ►

Expert Discussion: What’s New and Noteworthy in C. difficile?

This 4-part video roundtable series will aid pharmacists in applying evidence-based treatment strategies in the treatment and management of patients with CDI. It is critical for healthcare professionals to be aware of updates to treatment guidelines, data supporting therapeutic options and strategies for reducing CDI recurrence.

Learn More ►

Expert Guidance on the Pharmacist’s Role in HIV Care Across the Continuum: Individualizing and Improving Care from Prevention to Treatment

This activity will improve the knowledge and competence of pharmacists about antiretroviraltherapy (ART) regimens for patients living with HIV, including emerging agents andPre-Exposure Prophylaxis (PrEP).

Learn More ►

Expert Review of Recent Health System Specialty Pharmacy Research Studies, Part 1

In this 2-part CE webinar series, pharmacists and pharmacy technicians will learn about the design and findings of four research studies that evaluated how fully-integrated health system specialty pharmacy services impact patient care and clinical outcomes.

Learn More ►

Expert Review of Recent Health System Specialty Pharmacy Research Studies, Part 2

In this 2-part CE webinar series, pharmacists and pharmacy technicians will learn about the design and findings of four research studies that evaluated how fully-integrated health system specialty pharmacy services impact patient care and clinical outcomes.

Learn More ►

Fertility Module #1: Fertility Care Considerations: Introduction to Infertility

Module 1 reviews the physiology of reproduction and the effects of hormone regulation on reproduction. The risk factors for infertility as well as the diagnostic tests used in identifying infertility will be discussed.

Learn More ►

Fertility Module #2: Infertility: Therapeutics and Medication Profiles

Module 2 will review the mechanism of action of the typical agents used to affect infertility. Medication adverse effects, administration, storage, and other information regarding these agents will also be discussed.

Learn More ►

Fertility Module #3: Infertility: Protocols and Patient Management

Module 3 reviews the appropriate pharmacological and non-pharmacological protocols typically used to address infertility.

Learn More ►

Fertility Module #4: Fertility Care Considerations: Special Populations and Considerations

Module 4 will conclude with addressing some of the special considerations in patients with infertility issues. The role of the nurse, specialty pharmacy and the pharmacy care plan along with issues of adherence will also be discussed.

Learn More ►

Growth Hormone Deficiency

The purpose of this CE is to give technicians an overview of growth hormone deficiency (GHD) in children and adults in order to better understand and engage this patient population.

Learn More ►

Hemophilia in Specialty Pharmacy

This activity will review hemophilia as it pertains to specialty pharmacy. Treatment choices for hemophilia A and B are discussed. Inhibitor development will be explained including diagnosis and treatment options as well as the impact to therapy.

Learn More ►

Hepatitis C: A Technician’s Guide

Technicians will learn about the presentation, prevalence, and risk factors for contractinghepatitis C virus (HCV). HCV prognosis, goals of therapy, and guideline-recommendedtreatment options will be discussed.

Learn More ►

Hepatitis C Module #1: The abCs of HCV

Hepatitis C virus (HCV) has become one of the most common infections worldwide. This comprehensive four module program will provide a complete overview of HCV. Module One will address the epidemiology, diagnosis, and pathophysiology of HCV. Staging of HCV will also be reviewed.

Learn More ►

Hepatitis C Module #2: Direct Acting Antivirals for the Treatment of Hepatitis C

Hepatitis C virus (HCV) has become one of the most common infections worldwide. This comprehensive four module program will provide a complete overview of HCV. Module Two will discuss the evolution of HCV treatments and the pharmacology of current agents. Possible drug interactions will also be reviewed.

Learn More ►

Hepatitis C Module #3: HCV Drug Therapy Management

Hepatitis C virus (HCV) has become one of the most common infections worldwide. This comprehensive four module program will provide a complete overview of HCV. Module Three will address patient specific factors, treatment options, and the monitoring of HCV treatments. Pharmacist interventions will also be discussed.

Learn More ►

Hepatitis C Module #4: Treatment of HCV in Special Populations, HCV Resistance, and the Future of HCV Therapy

Hepatitis C virus (HCV) has become one of the most common infections worldwide. This comprehensive four module program will provide a complete overview of HCV. Module Four will include appropriateness of therapy for special populations, resistance issues, and emerging treatment options. The role of the specialty pharmacist will also be addressed.

Learn More ►

High-Alert Medications Heparin, Concentrated Electrolytes, and Magnesium: Practical Strategies in Pursuit of Safety

Join the ISMP faculty as we focus particular attention on the potential safe use risks with heparin, concentrated electrolytes, and magnesium using the results from ISMP Medication Safety Self Assessment® for High-Alert Medications.

Learn More ►

High-Alert Medications Insulin and Vasopressors: Practical Strategies in Pursuit of Safety

Join the ISMP faculty as we examine and define the importance of high-alert medications as part of routine patient care and review the results of ISMP Medication Safety Self Assessment® for High-Alert Medications with particular attention to vasopressors and insulin.

Learn More ►

IBD: Medication and Patient Management

This activity addresses treatment goals, options for therapy, monitoring parameters and the pharmacist's role in Inflammatory Bowel Disease (IBD) therapy management.

Learn More ►

Incorporating the Newest CLSI Recommendations for Antimicrobial Susceptibility Testing into your Stewardship Activities

This annual webcast provides updates on hot topics related to antibiotic stewardship and microbiological testing. This year’s webcast will include recent CLSI antimicrobial susceptibility testing updates for gram positive/gram negative bacteria and Candida species. We will also discuss ways to incorporate these changes in your antimicrobial stewardship efforts.

Learn More ►

Irritable Bowel Disease

This activity discusses both Ulcerative Colitis and Crohn’s, the stepwise approach to treatment considerations, and financial assistance options to provide the technician with a better understanding of these disease processes and the therapies used to treat them.

Learn More ►

Management of Anticoagulant-Related Major Bleeding: Clinical Updates and Best Practices for Health-System Pharmacists

This activity will improve the knowledge and competence of pharmacists about the management of anticoagulant-related bleeding, including recent guideline updates, selecting appropriate reversal agents and dosing strategies.

Learn More ►

Management of Peanut Allergy

This presentation discusses the prevalence, pathophysiology, and epidemiology for IgE-mediated food allergy with a special focus on peanut allergy.

Learn More ►

Managing Chemotherapy-Induced Nausea and Vomiting and Oral Anti-Cancer Adverse Effects

This activity provides an update for pharmacists and nurses on the antiemetic therapies available and techniques for managing the unique adverse events associated with oral chemotherapy.

Learn More ►

Maximizing Automation and Technology Innovation

This activity will discuss ways that technology can provide value to the patient experience. Solutions to improve pharmacy operations and strategies to implement new technology will also be discussed.

Learn More ►

Medicare Part B

This activity will explain the basic requirements for billing claims to Medicare Part B and how to stay compliant with the most current Medicare guidelines. It will go over required components of a prescription, what is needed for the proof of delivery of medications and supplies, and which drugs are covered by Medicare Part B.

Learn More ►

Melanoma Diagnosis and Management Considerations

This educational activity will provide an overview of the diagnosis, epidemiology, risk factors, pathology, and staging of melanoma. This activity will include an in-depth review of treatments for melanoma. Adverse events, appropriate patient monitoring, and adherence will also be discussed.

Learn More ►

Migraine: Diagnosis, Treatment Strategies and an Update of the Recent Therapeutic Advances

This activity will provide a review of the migraine disorder, available treatment options and highlights the recent therapeutic advancements.

Learn More ►

Mobile Patient Engagement: Using Technology to Break Barriers and Reach Patients in New Ways

This activity is an engaging, detailed guide into technology use cases being employed in the market, how they are making dramatic differences in how pharmacists interact with patients, and the results from those interactions.

Learn More ►

MS-101: Pathogenesis, Diagnostic and Clinical Course Treatment Considerations in MS (A CSPE Core Curriculum Series)

Multiple sclerosis (MS) affects an estimated 400,000 people in the U.S., with approximately 10,000 new cases reported every year. This activity provides an introduction to MS pathology, epidemiology, and symptom management to specialty pharmacists and nurses.

Learn More ►

MS-102: Navigating the MS Therapeutic Landscape (A CSPE Core Curriculum Series)

As a chronic and progressive neurologic disease that requires lifelong, dynamic treatment via costly, high-touch medications that also require special handling and storage, multiple sclerosis therapies are often delivered via specialty pharmacy programs. This activity provides an in-depth discussion of the various therapies used in the treatment of MS.

Learn More ►

MS-103: The Role of the Specialty Pharmacy Professional in Managing MS Treatment: Care Transitions, Patient Education/Adherence, and Financial Considerations (A CSPE Core Curriculum Series)

Multiple sclerosis (MS) affects an estimated 400,000 people in the U.S., with approximately 10,000 new cases reported every year. This activity discusses the transitions of care, patient adherence strategies and financial considerations in the management of MS.

Learn More ►

MS-104: Optimizing MS Treatment: Case Studies and Applications in Specialty Pharmacy Practice (A CSPE Core Curriculum Series)

As a chronic and progressive neurologic disease that requires lifelong, dynamic treatment via costly, high-touch medications that also require special handling and storage, multiple sclerosis therapies are often delivered via specialty pharmacy programs. This capstone activity of the MS curriculum uses case studies to allow participants to apply what was learned in modules MS-101 through MS-103.

Learn More ►

Multidrug Resistant Organisms: Detection, Epidemiology, and Management (BCIDP Activity)

This activity provides valuable insights from expert faculty regarding the epidemiology and pharmacotherapeutic management of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), extended-spectrum beta-lactamases (ESBLs), carbapenem-resistant Enterobacterales (CRE), multidrug-resistant Pseudomonas, and carbapenem-resistant Acinetobacter baumannii (CRAB).

Learn More ►

Multiple Sclerosis and Role of Specialty Pharmacy

This educational activity tool will address the disease state of multiple sclerosis. Topics discussed will include the diagnostic process of multiple sclerosis, common specialty medications prescribed for disease management, patient factors specific to treatment, and the main roles specialty pharmacies have to offer in managing patients’ medications.

Learn More ►

Muscular Dystrophy: Causes, Symptoms and Treatment Options

This activity will review the nine different types of muscular dystrophy, their clinical presentation and prognosis. It also focuses on available pharmacologic treatment options as well as examples of those in clinical trials.

Learn More ►

New Antibiotics Now and Beyond: What’s in your Bucket?

This activity will examine antibiotics approved during this period, their spectrum of activity, data supporting use and potential place in therapy as well as important new indications for some important antibiotics.

Learn More ►

Nutrition in Cancer Care

Nutrition therapy is an important part of managing oncology patients' adverse effects and hopefully, by managing these issues, it will increase the patient’s quality of life. It is imperative healthcare professionals recognize and understand management strategies in oncology patients with anorexia, dysphagia, mucositis, and xerostomia.

Learn More ►

Opioid Stewardship® - A Certificate Program for Healthcare Professionals

The Opioid Stewardship Certificate Program is a practice-based activity for clinicians impacted by the opioid crisis. The program emphasizes a health care team approach to foster the development of a strong knowledgebase regarding opioids, pain management, opioid use disorder and skills to impact the appropriate use of opioids in healthcare and our communities.

Learn More ►

Opioid Use Disorder: Treatment and Recovery Options

This activity will highlight the ongoing struggles that are faced within the treatment of opioid use disorder (OUD), including stigma that prevents effective engagement in treatment, as well as the continued loss of life due to opioid-related overdoses.

Learn More ►

Optimization of IVIG and SCIG: Patient Centered Care and the Role of Specialty Pharmacies

This activity will focus on primary immune deficiency along with practicalities and pitfalls when prescribing therapies for these patients. Optimizing therapy and the role of the specialty pharmacist will also be discussed.

Learn More ►

Optimizing Diagnostics in ASP Implementation - An African Perspective

Join CIDRAP-ASP for a webinar reviewing diagnostics as a part of antimicrobial stewardship program implementation from an African perspective. Speakers will cover experiences implementing antimicrobial stewardship programs in their regions, and how to optimize access to and the use of diagnostics in ASPs from an African perspective.

Learn More ►

Oral Oncology - Clinical Module for Pharmacy Technicians, Part 1

This module is for pharmacy technicians who are interested in exploring and expanding their knowledge of oncology patient management. Topics to be discussed include overview of cancer and important terminology in cancer care, financial barriers to oncology patient care, safe handling of oncology drugs and an introduction to cancer treatment regimens where colorectal cancer treatments are reviewed.

Learn More ►

Oral Oncology - Clinical Module for Pharmacy Technicians, Part 2

This module is for pharmacy technicians who are interested in exploring oncology, or those interested in expanding their knowledge of oncology patient management. In this module, faculty will discuss treatment regimens for breast, prostate and lung cancers.

Learn More ►

Ovarian Cancer

This session will cover the mechanism of action of the PARP inhibitors and the efficacy and safety parameters of the ovarian cancer treatment options available.

Learn More ►

Overview of Gene Therapy

The field of gene therapy is evolving and rapidly advancing. Organizational readiness should be a priority to address the predicted influx of gene therapies into the marketplace.

Learn More ►

Parkinson’s Disease: Overview and Treatment

The focus of this activity is to provide an overviewof the Parkinson’s disease, stages of the disease progression, current and futuretherapies. The activity also reviews challenges to medication adherence as well asstrategies to improve it.

Learn More ►

Pathogens are Coming, Brace Yourself Against Gram Negative Resistance

This activity will discuss several new antimicrobial agents active against resistant Gram-negative pathogens approved in recent years.

Learn More ►

Pharmacovigilance: An Introduction to Postmarketing Drug Safety Surveillance

This activity will provide pharmacists with education on several topics surrounding post-marketing drug safety surveillance, with particular emphasis on how adverse event reports are reported, collected, and analyzed by the U.S. Food and Drug Administration, and more.

Learn More ►

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and the Treatment of Hypercholesterolemia

This activity lays the foundation for understanding the disease state, the various clinical aspects of the drug class, and the pipeline involving this class of specialty pharmacy medications.

Learn More ►

Prostate Cancer

It is imperative that pharmacists are aware of the novel agents available for prostate cancer. This session will cover the mechanism of action of each of the prostate cancer therapeutics available and the efficacy and safety parameters.

Learn More ►

PsA/PsO – Specialty Technician Guide for Psoriasis

This activity is designed to enhance the knowledgebase for pharmacy technicians on the topic of psoriasis through a review of the different types and locations, goals of treatment and current treatment options.

Learn More ►

Psoriasis and Psoriatic Arthritis

This educational activity will review the incidence, pathophysiology, diagnosis, signs and symptoms of these diseases. Treatment guidelines available, along with non-pharmacological and pharmacological treatments, will also be discussed.

Learn More ►

Raising the Bar on Sterile Compounding Safety

This activity will take you from the spark that triggered the Institute for Safe Medication Practices virtual sterile compounding safety summit, through the objectives, targets and structure used to develop new ISMP Best Practice Guidelines, concluding with a discussion of one organization’s journey using various sterile compounding technologies to reduce the risk for errors and the steps they took to minimize threats to safe technology use.

Learn More ►

Recognition and Management of Bacterial Pneumonia in Patients with COVID-19, #1: Overview and Diagnosis

This series will increase the knowledge, competence, and performance of pharmacists in the recognition and management of bacterial pneumonia in patients with COVID-19. View all three to get the most from this engaging series!

Learn More ►

Recognition and Management of Bacterial Pneumonia in Patients with COVID-19, #2: Antimicrobial Stewardship and Treatment

This series will increase the knowledge, competence, and performance of pharmacists in the recognition and management of bacterial pneumonia in patients with COVID-19. View all three to get the most from this engaging series!

Learn More ►

Recognition and Management of Bacterial Pneumonia in Patients with COVID-19, #3: Best Practices Roundtable

This series will increase the knowledge, competence, and performance of pharmacists in the recognition and management of bacterial pneumonia in patients with COVID-19. View all three to get the most from this engaging series!

Learn More ►

Refocusing on Medication Safety: Best Practices for Injection Safety

This webinar will focus on the challenges of the global COVID-19 pandemic, how practitioners can prevent medication errors despite this disruption, how to refocus on best practices related to IV push medications in adults, and how these strategies can have additional workflow benefits.

Learn More ►

Research Platform Presentations

This activity will feature five projects that represent some of the exceptional research being conducted by SIDP members.

Learn More ►

Research Platform Presentations 2020

These four projects represent some of the exceptional research being conducted by SIDP members.

Learn More ►

Research Platform Presentations 2021

Four projects are presented that represent some of the exceptional research being conducted by SIDP members.

Learn More ►

Rheumatoid Arthritis

This educational activity will review the pathophysiology, clinical presentation, and diagnosis of RA. The current ACR guidelines for treatment will be reviewed along with the current therapies. Methods used to measure and monitor the effectiveness of treatment, along with patient education, will also be discussed.

Learn More ►

Rheumatology: Diagnosis, Treatment, and Financial Resources

This educational activity will address different rheumatological disease states. Topics to be addressed will include presentation, prevalence, and risk factors, goals of therapy and prognosis, outline of current treatment options, as well as financial assistance that may be available for patients.

Learn More ►

Setting Susceptibility Breakpoints: A Look Behind the Curtain

Susceptibility breakpoints and a review of setting, revising and assessing their values will be discussed. Examining data sources, different approaches, and indicators for reassessment will offer key points of insight in this activity.

Learn More ►

Sexual Harassment: Awareness and Prevention in the Healthcare Workplace-2022 (Pharmacist/Pharmacy Technician)

This activity will assist in increasing awareness of what constitutes sexual harassment, the impact of harassment, what to do if you are harassed or a witness, the responsibilities of the employer, and the protections that are in place for those reporting harassment.

Learn More ►

Sexual Harassment: Awareness and Prevention in the Healthcare Workplace (Nurse/Physician/Physician Assistant)

This activity will assist in increasing awareness of what constitutes sexual harassment, the impact of harassment, what to do if you are harassed or a witness, the responsibilities of the employer, and the protections that are in place for those reporting harassment.

Learn More ►

Should Antimicrobial Doses be Fixed? Weight Weight...Don’t Tell Me!

This webinar will provide a historical and contemporary perspective on the definition of obesity and body size description. The pharmacologic approach to initial and maintenance dose selection will be reviewed to harmonize current divergent approaches. Patient case and drug case scenarios will illustrate pragmatic methods of informing antibiotic dose selection in obesity.

Learn More ►

SIDP Annual Meeting 2021 (BCIDP +ACPE Credit): Spiraling Empiricism vs. Science; Critical Updates in the Treatment of HIV and STIs; Blood Boiling Debate

This bundle from the SIDP Annual Meeting includes the following sessions for BCIDP credit: Spiraling Empiricism vs. Science: The Stewardship Dilemma of Breakthrough Fungal Infections; Critical Updates in the Treatment of HIV and STIs; Blood Boiling Debate: Can I Really Use Ceftriaxone for MSSA Bacteremia?

Learn More ►

SIDP Antimicrobial Stewardship - A Certificate Program for Pharmacists

The Antimicrobial Stewardship Program is an innovative and intensive practice-based activity that focuses on the pharmacist's role in the appropriate use of antimicrobial agents.

Learn More ►

SIDP Antimicrobial Stewardship – A Long-Term Care Certificate Program for Pharmacists

The Society of Infectious Diseases Pharmacists (SIDP) is pleased to offer the Long-Term Care (LTC) Antimicrobial Stewardship Certificate Program. This is a practice-based certificate program focused on the role pharmacists play in the appropriate use of antimicrobial agents.

Learn More ►

SIDP COVID-19 Video: Molnupiravir/Oral Therapies

Members from the Society of Infectious Diseases Pharmacists have prepared brief, evidence-based reviews of potential pharmacotherapeutic treatment options for COVID-19. The latest video presentations and handouts are available at www.SIDP.org/COVID19.

Learn More ►

SIDP COVID-19 Video: Tixagevimab/cilgavimab (Evusheld)

Members from the Society of Infectious Diseases Pharmacists have prepared brief, evidence-based reviews of potential pharmacotherapeutic treatment options for COVID-19. The latest video presentations and handouts are available at www.SIDP.org/COVID19.

Learn More ►

SIDP Journal Club Series 2021: Addressing the Trials and Tribulations of Procalcitonin as an Antimicrobial Stewardship Tool

Journal Club 2021 #1: Review an open-access journal article and complete a step-by-step discussion guide to gain insights before completing CE and/or BCIDP credit.

Learn More ►

SIDP Journal Club Series 2021: Celebrating 30 Years of SIDP: Assessing the impact of the Hartford nomogram and once daily aminoglycoside dosing on the modern treatment of gram-negative infections

Journal Club 2021 #2: Review an open-access journal article and complete a step-by-step discussion guide to gain insights before completing CE and/or BCIDP credit.

Learn More ►

SIDP Journal Club Series 2021: Delayed Antibiotic Prescribing for Respiratory Tract Infections

Journal Club 2021 #3: Review an open-access journal article and complete a step-by-step discussion guide to gain insights before completing CE and/or BCIDP credit.

Learn More ►

SIDP Journal Club Series 2021: Assessing the Utility of Piperacillin-tazobactam Against Meropenem When Treating Bloodstream Infections Caused By AmpC b-lactamase Producing Bacteria

Journal Club 2021 #4: Review an open-access journal article and complete a step-by-step discussion guide to gain insights before completing CE and/or BCIDP credit.

Learn More ►

SIDP Journal Club Series 2022: Role of Repeated Measures of Fungal Biomarkers for the Diagnosis of Invasive Candidiasis in the Critically Ill

Journal Club 2022 #1: Review an open-access journal article and complete a step-by-step discussion guide to gain insights before completing CE and/or BCIDP credit.

Learn More ►

SIDP Journal Club Series 2022: Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study

Journal Club 2022 #2: Review an open-access journal article and complete a step-by-step discussion guide to gain insights before completing CE and/or BCIDP credit.

Learn More ►

SIDP Journal Club Series 2022: Role of Cytomegalovirus Prophylaxis for Solid Organ Transplant Recipients Undergoing Hemodialysis

Journal Club 2022 #3: Review an open-access journal article and complete a step-by-step discussion guide to gain insights before completing CE and/or BCIDP credit.

Learn More ►

SIDP Journal Club Series: Should we SWITCH to Short-Course Intravenous Antibiotics for Cellulitis?

Journal Club 2020 #1: Review an open-access journal article and complete a step-by-step discussion guide to gain insights before completing CE credit.

Learn More ►

SIDP Journal Club Series: Is early oral therapy for low-risk Staphylococcus aureus bacteremia a reality?

Journal Club 2020 #3: Review an open-access journal article and complete a step-by-step discussion guide to gain insights before completing CE credit.

Learn More ►

SIDP Journal Club Series: Ceftriaxone Outpatient Parenteral Antimicrobial Therapy for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infection

Journal Club 2020 #4: Review an open-access journal article and complete a step-by-step discussion guide to gain insights before completing CE credit.

Learn More ►

SIDP’s Recap of IDWeek 2019 - Part 1: Late Breaker Trials and #WhyIVaccinate; Practice-changing Publications ft. David van Duin

Ryan Shields and Erin McCreary review key posters, presentations, and other data from the IDWeek 2019 meeting. Episode 1: Late Breaker Trials and #WhyIVaccinate. Episode 2: Practice-changing publications ft. David van Duin

Learn More ►

SIDP’s Recap of IDWeek 2019 - Part 2: Provocative Titles and Pro-Con Debates; Pumpkin Spice Lessons: Phages, Posters, and Dr. Paul Sax

Ryan Shields and Erin McCreary review key posters, presentations, and other data from the IDWeek 2019 meeting. Episode 3: Provocative Titles and Pro-Con Debates. Episode 4: Pumpkin Spice Lessons: Phages, Posters, and Dr. Paul Sax.

Learn More ►

SIDP Research Mini-Series

This 4-part Research Series is an introductory program that focuses on imparting best practices on conducting antimicrobial stewardship-related research. This program reviews idea generation, protocol development, data collection set-up and management, data analysis, and research dissemination.

Learn More ►

Simple Solutions to the Complicated Challenges of Biosimilar Uptake in the US Market

This activity is designed to increase your understanding of the biosimilar, including a review of biologic medications, history, spending and usage. Strategies for implementation of biosimilars will provide key take-aways for pharmacists and pharmacy technicians.

Learn More ►

Solid Organ Transplant

This module is for pharmacy technicians who are interested in exploring and expanding their knowledge of solid organ transplant patient management.

Learn More ►

Specialty Pharmaceutical Pipeline Updates

This activity will review the most recent approvals and discuss near-term products in the pipeline and specialty drug development trends.

Learn More ►

Specialty Technician CE: Cystic Fibrosis

This overview of the Cystic Fibrosis (CF) disease state continuing education for pharmacy technicians covers a variety of topics related to treatment of CF. The presentation is pertinent to Specialty Technicians, CF Clinic Liaisons, and other technicians seeking education on CF.

Learn More ►

Specialty Technician CE: Inflammatory Module

This activity is designed to introduce the most prevalent inflammatory conditions and their associated treatments to better support pharmacy technicians in their daily responsibilities caring for patients.

Learn More ►

Spiraling Empiricism vs. Science: The Stewardship Dilemma of Breakthrough Fungal Infections

This activity will focus on breakthrough fungal infections and potential issues on the horizon as well as their importance from a stewardship perspective. Faculty will discuss suggestions and examples of dealing with the problems of breakthrough fungal infections.

Learn More ►

State of Care 2020: Autoimmune Disorders

This activity will review current standards of care and recent guideline updates for autoimmune disease states. Newly approved agents and their safety and efficacy based on recent studies will also be discussed.

Learn More ►

State of Care 2020: HIV

This activity will discuss the state of care, specifically focusing on HIV and managing HIV from a specialty pharmacy perspective.

Learn More ►

State of Care 2020: Immune Globulin

Presenters will examine current standards of care for Immune Globulin. A review of agents for this disease state will be included with best practices for helping patients.

Learn More ►

State of Care 2020: Oral Oncology

This activity will review current standards of care for oral oncology in the treatment of gastrointestinal stromal tumor (GIST) and non-small cell lung cancer (NSCLC).

Learn More ►

State of Care 2020: Transplant

This activity will review current standards of care for transplant. Newly approved agents and best practices for managing patients will also be discussed.

Learn More ►

State of Care: Cystic Fibrosis

This activity will review the nature of Cystic Fibrosis, the impact on patients and ways to help them manage the disease. Faculty will also discuss current and evolving treatments for patients with CF.

Learn More ►

State of Care: Hepatology

This activity will review the current standards of care for Hepatology (HepC, NASH), and ways to help patients manage the disease. A review of the newest agents for this disease state will also be included.

Learn More ►

State of Care: Inflammatory Diseases

This activity will review the current standards of care for Inflammatory Diseases (Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis). A review of the newest agents for this disease state will be included with discussion on best practices for helping patients manage these inflammatory conditions.

Learn More ►

State of Care: Oncology/Hematology

This activity will focus on acute myeloid leukemia and multiple myeloma with a review of the current standards of care for this disease state. Ways to help patients manage the disease and a review of the newest agents for this disease state will also be included.

Learn More ►

Sterile Compounding: Practical Knowledge and Application - A Virtual Reality Certificate Program for Pharmacy Professionals

The Sterile Compounding Certificate Program is an online course for pharmacists and pharmacy technicians interested in developing and demonstrating expertise in sterile compounding. The program utilizes self-study modules to gain expert understanding of compounding standards and regulations, and a practical component in a virtual cleanroom environment where users will learn and practice sterile compounding skills and technique.

Learn More ►

Surveillance powered by Diagnostics

Join CIDRAP-ASP for a webinar discussing the importance of surveillance for qualifying and quantifying antimicrobial resistance (AMR), and learn about the challenges of conducting surveillance in low and middle-income settings.

Learn More ►

Targeted Oral Chemotherapy for Lung Cancer

The management of SCLC and NSCLC is complex and staying up-to-date on the screening, diaganosis and treatment options is crucial for the specialty pharmacist caring for these patients. This activity includes a patient case study to help thoroughly explore the challenges with this disease.

Learn More ►

The Evolving Value of a Laboratory - Stewardship Partnership: Cases in Susceptibility Testing, Rapid Diagnostics and More!

Join us for this annual webcast that provides updates on hot topics related to antibiotic stewardship and microbiological testing. This year’s webcast will include recent CLSI antimicrobial susceptibility testing updates. We will discuss ways to incorporate these changes in your antimicrobial stewardship efforts and collaboration opportunities with stewardship and the microbiology laboratory.

Learn More ►

The Impact of Acute Major Bleeding: Patient Outcomes, Costs, and Practical Considerations

This activity will evaluate the clinical impact of acute major bleeding and examine safety and efficacy data surrounding the use of oral anticoagulant reversal agents.

Learn More ►

The Inside Track on Drug Naming Safety Standards

This program will take the participant down the “drug naming pathway" to learn the inner workings and decisions involving behind the scenes. Not widely known by most healthcare practitioners, learners will hear first-hand from several experts including a global pharmaceutical company, the Food and Drug Administration, and the European Medicines Agency about the role each plays in the drug name development process.

Learn More ►

The Level is in the Details: Beta-lactam Therapeutic Drug Monitoring

This episode of Breakpoints: The SIDP Podcast, includes an expert panel discussion surrounding the utility of beta-lactam therapeutic drug monitoring (BL-TDM). In a dynamic and wide-ranging conversation, panelists address key concepts such as beta-lactam targets and exposure thresholds, populations that may uniquely benefit from BL-TDM, the relationship between BL-TDM and clinical outcomes, and practical considerations for implementation.

Learn More ►

The Pharmacy Technician’s Role in the Management of the Specialty Pharmacy Patient

The role of the pharmacy technician is critical to ensure the onboarding process and ongoing management is efficient and effective for the patient. This activity will review the key considerations for the pharmacy technician when managing specialty pharmacy patients.

Learn More ►

The Psychology and Neuroscience of Adherence and Compliance

This activity will begin with the science of decision-making and the role of emotions. Several compliance modules will be discussed to provide practical ways to improve adherence and compliance.

Learn More ►

The Role and Impact of Pharmacy Technicians in Health System Specialty Pharmacy Services

In this CE webinar, pharmacy technicians currently practicing in the health system specialty pharmacy setting will discuss the day-to-day responsibilities of a specialty pharmacy liaison, how specialty pharmacy liaisons interact with and support patients, pharmacists, and other providers, and the impact specialty pharmacy liaisons have on medication access, adherence, and patient outcomes.

Learn More ►

Treatment of Rare Seizure Disorders within Specialty Pharmacy

The initial diagnosis of epilepsy is often devastating for families. The patient and parents must be helped to understand the nature of epilepsy and its management, including etiology, prognosis, safety issues and treatment options. The goal of this presentation is to provide pharmacists with knowledge and tools to serve this patient population and their families.

Learn More ►

Treatment Options in Relapsed/Refractory Multiple Myeloma: Pharmacists’ Perspectives

This activity is designed to improve the knowledge and competence of pharmacists about the treatment options for relapsed/refractory multiple myeloma (R/R MM), and about designing optimal therapeutic regimens, including monitoring parameters and appropriate patient counseling, with consideration for individual patient and disease characteristics in this patient population.

Learn More ►

Treatment Strategies and Safety Updates in Multiple Sclerosis

MS treatment options have rapidly evolved and multiple safety updates for treatments were released toward the end of 2018. This activity will focus on the updated research and recommendations to provide pharmacists short and long-term management strategies for patients with MS and help to ensure improved overall care coordination.

Learn More ►

Update on Treatment of Moderate to Severe Asthma with Biologics

This continuing education activity will use a patient case to review the Global Initiative for Asthma (GINA)recommendations, describe type 2 inflammation in asthma and discuss currently availableadd-on type 2 targeted treatments for severe asthma.

Learn More ►

US Specialty Pharmaceutical Trends, Issues and Outlook for NASP

This activity will discuss a number of topics including COVID, Medical claims, telehealth and different specialties. The faculty will discuss where we are now and a deep dive into specialty versus traditional pharmacy and a look ahead to the future.

Learn More ►

Utilizing Technology for Patient Communication in Specialty

This activity will discuss ways to identify and implement patient engagement technologies. Methods to assess implementation will also be shared.

Learn More ►

Vancomycin Dosing: From Trough to AUC

In this activity, participants will better understand appropriate utilization of AUC-based dosing, including evidence-based support of usage and implementation strategies.

Learn More ►

What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 1

Ryan Shields and Erin McCreary discuss notable infectious diseases publications from the first half of 2020.

Learn More ►

What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 2

Ryan Shields and Erin McCreary discuss notable infectious diseases publications from the first half of 2020.

Learn More ►